QuidelOrtho Corp
QDEL- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001906324
No open-market purchases or sales by QuidelOrtho Corp insiders were filed in the last 90 days; 245 institutions reported holding it in 13F filings for Q2 2026, worth $1.45B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in QuidelOrtho Corp as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 353
- −4 vs. Q4 2021
- Shares held
- 37.3M
- +364.8K (+1.0%) vs. Q4 2021
- Total value
- $4.19B
- −$791.6M (−15.9%) vs. Q4 2021
- New holders
- 65
- 143 more added
- Sold out
- 69
- 96 more reduced
4 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QDEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 245 | $1.45B |
| Q1 2026 | 239 | $1.35B |
| Q4 2025 | 244 | $2.35B |
| Q3 2025 | 255 | $2.41B |
| Q2 2025 | 264 | $2.29B |
| Q1 2025 | 266 | $2.63B |
| Q4 2024 | 275 | $3.27B |
| Q3 2024 | 263 | $3.28B |
| Q2 2024 | 262 | $2.26B |
| Q1 2024 | 271 | $3.12B |
| Q4 2023 | 306 | $4.89B |
| Q3 2023 | 305 | $4.70B |
| Q2 2023 | 313 | $5.24B |
| Q1 2023 | 333 | $5.62B |
| Q4 2022 | 347 | $5.41B |
| Q3 2022 | 315 | $4.54B |
| Q2 2022 | 348 | $5.70B |
| Q1 2022 | 353 | $4.19B |
| Q4 2021 | 361 | $4.98B |
| Q3 2021 | 314 | $5.09B |
| Q2 2021 | 331 | $4.87B |
| Q1 2021 | 350 | $4.62B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding QuidelOrtho Corp; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meridian Wealth Management, LLC | 0 | $0 | 0.00% | −1,513−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Maverick Capital LtdSuperinvestorMaverick Capital | 0 | $0 | 0.00% | −549−100.0% | Sold out |
| Harel Insurance Investments & Financial Services Ltd. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Vestor Capital, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| City State Bank | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Stonebridge Financial Planning Group, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Lee Financial Co | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Motley Fool Asset Management LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Harvest Group Wealth Management, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| TAP Consulting, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Sutton Wealth Advisors Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| 6 Meridian | – | – | – | – | Not filed |
| Sphinx Trading, LP | – | – | – | – | Not filed |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |